The number of Swiss victims of Depakine may be underestimated

The antiepileptic drug Depakine is once again at the center of a public health scandal. Responsible for serious foetal malformations, a study co-authored by the CHUV suggests that the number of Depakine victims in Switzerland is much higher than the figure cited by Swissmedic. A first complaint has been filed in Switzerland.